June 26, 2026June 26, 2026Latest NewsBy domainlabs8@gmail.com0 0

U.S. says 'slight progress' in Iran talks amid uncertainty about whether war will resume – PBS

Samy Magdy, Associated Press Samy Magdy, Associated Press Sam Mednick, Associated Press Sam Mednick, Associated Press Leave your feedbackTEL AVIV, Israel (AP) — U.S. Secretary of State Marco Rubio said Friday there was “slight progress” during talks with Iran amid uncertainty about whether a deal will be reached or war will resume.WATCH: Trump says he’s in ‘no hurry’ to make...

June 26, 2026June 26, 2026Latest NewsBy domainlabs8@gmail.com0 0

FDA OKs first human trial of oral MS remyelination therapy PTD802 – Multiple Sclerosis News Today

New US study to evaluate treatment’s safety, tolerability in healthy volunteersWritten by Michela Luciano, PhD | June 25, 2026 Damage to the myelin sheath, the protective coating surrounding nerve fibers, is at the core of multiple sclerosis. (Image from iStock)The FDA has given the green light for a first-in-human trial testing PTD802, an oral remyelination therapy for multiple sclerosis.The treatment...

June 26, 2026June 26, 2026AIBy domainlabs8@gmail.com0 0

Calendly Review: Professional Scheduling Automation – quasa.io

#QUA #Quasa #calendlyCalendly (featured on Quasa.io/projects/calendly) is the world’s leading scheduling automation platform.It eliminates the back-and-forth of finding meeting times by letting you share your availability so others can book meetings directly into your calendar.At its core, Calendly automates the entire meeting lifecycle — from scheduling to reminders and follow-ups.Key highlights include:It’s perfect for sales teams, recruiters, consultants, agencies, educators,...